Concepedia

Wandong Yu

WY

8

Publications

295

Citations

8

H-Index

2016

Active since

Affiliations

Fudan University(Current)

State Key Laboratory of Oncogene and Related Genes

Renji Hospital

Shanghai Cancer Institute

Wandong Yu is an author at Fudan University specializing in oncology, urology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2016–2021

8

Publications

8

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc

Jianchao Ge, Wandong Yu, Junhong Li et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 66 citations · Full text

<p>KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer</p>

Jun Zhang, Wandong Yu, Xilong Wang et al. · OncoTargets and Therapy · 2020 · 62 citations · Full text

PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)

Johann S. de Bono, Ugo De Giorgi, Christophe Massard et al. · Annals of Oncology · 2016 · 53 citations · Full text

, , +9

Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells

Qiang Wang, Ruixian Peng, Boshi Wang et al. · Cancer Biomarkers · 2018 · 38 citations · Full text

Network Pharmacology of Yougui Pill Combined with Buzhong Yiqi Decoction for the Treatment of Sexual Dysfunction

Yangyun Wang, Wandong Yu, Chaoliang Shi et al. · Evidence-based Complementary and Alternative Medicine · 2019 · 29 citations · Full text

Rows per page

1–5 of 8